title: Reversal of direct oral anticoagulants for liver transplantation in cirrhosis: A step forward.
authors.affiliation: Division of Gastroenterology and Hepatology, University of Virginia Health System, University of Virginia, Charlottesville, VA.
authors.forename: Nicolas M
authors.initials: NM
authors.lastname: Intagliata
authors.affiliation: Division of Hematology and Oncology, University of Virginia Health System, University of Virginia, Charlottesville, VA.
authors.forename: Hillary
authors.initials: H
authors.lastname: Maitland
authors.affiliation: Department of Surgery, University of Virginia Health System, University of Virginia, Charlottesville, VA.
authors.forename: Shawn
authors.initials: S
authors.lastname: Pellitier
authors.affiliation: Division of Gastroenterology and Hepatology, University of Virginia Health System, University of Virginia, Charlottesville, VA.
authors.forename: Stephen H
authors.initials: SH
authors.lastname: Caldwell
mesh_terms: D061605:Administration, Intravenous; D000284:Administration, Oral; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000925:Anticoagulants / Q000009:adverse effects*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D000069604:Dabigatran / Q000009:adverse effects; D058625:End Stage Liver Disease / Q000150:complications / Q000473:pathology / Q000601:surgery*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications / Q000473:pathology / Q000601:surgery; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011300:Preoperative Care / Q000379:methods; D012720:Severity of Illness Index; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; C000594745:idarucizumab; D000069604:Dabigatran